World’s Top Life Science Investor Summit Spotlights Panel on the Future of Intelligent and Digital Surgery with Premiere Thought-Leaders
One of the hottest areas in medtech is being featured as a key panel at the life science industry’s premiere investor summit.
Life Science Intelligence, a market intelligence & consulting company focused on covering the global medtech and healthtech markets, is bringing together an exciting panel at its third annual Life Science Intelligence (LSI) USA ’22 Emerging Medtech Summit.
The event has become an annual showcase for the future of life science technologies as well as the latest in market intelligence. The event has attracted close to a thousand in-person attendees with over 200 presenting medtech startups being vetted by hundreds of investors and strategics.
LSI USA ’22 will convene at the Monarch Beach Resort in Dana Point, CA the week of March 15. Having reached capacity the event is extending virtual badges for attendance.
The panel is made up of investors, innovators, and strategics to discuss where intelligent/digital surgery is today and where it is going.
The panel features the following thought-leaders:
- David Uffer, Senior Partner & VP, Alira Health (Moderator)
- Rachel Van Stratton-Kirk, Robotics & Digital Solutions, Ethicon (Panelist)
- Tal Wenderow, Venture Partner, Genesis MedTech (Panelist)
- Julian Nikolchev, Senior VP Corporate Development & Strategy, Intuitive Surgical (Panelist)
- Daniel Hawkins, CEO, Avail Medsystems (Panelist)
“Perioperative processes and procedures are increasingly being digitized with the advent of data analytics and AI in Medtech. Digitization of surgery is being developed in order to capture data at an accelerated pace,” shared David Uffer, panel moderator and Senior Partner and VP at Alira Health.
The Digital Surgery panel will explore how new technologies are capturing, sharing, and extracting value out of a data rich environment. High attendance is expected for the panel as investors are looking for answers on the current state and projected future of this new market.
“The evolution of surgery towards becoming more data-driven and digital, thus intelligent, has been a major area of interest for investors and strategics. We brought together the leading voices in the industry to cover what the future holds for investors and how the market landscape will change,” commented Scott Pantel, Founder and CEO of LSI.
For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybersecurity, go to AI-Techpark.com.